NCT03514069 Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma Status COMPLETED Phase PHASE1
NCT03495960 Study on Tailored Treatment in Elderly Patients With Newly Diagnosed Primary Lymphoma of Central Nervous System Status COMPLETED Phase PHASE2
NCT03495921 A Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and Temozolomide Status TERMINATED Phase PHASE3
NCT03491683 INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM) Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03480867 Pre-operative RT and TMZ in Patients With Newly Diagnosed GBM Diagnosed Glioblastoma. A Phase I Study. (PARADIGMA) Status WITHDRAWN Phase PHASE1
NCT03477110 Temozolomide, Radiation Therapy, and Tumor Treating Fields Therapy in Treating Participants With Glioblastoma Status COMPLETED Phase EARLY_PHASE1
NCT03463733 Hydroxy-urea and Temozolomide in Patients With a Recurrent Malignant Brain Tumor (Glioblastoma) Status UNKNOWN Phase PHASE1
NCT03426891 Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma Status COMPLETED Phase PHASE1
NCT03425292 A Longitudinal Assessment of Tumor Evolution in Patients With Brain Cancer Status COMPLETED Phase PHASE1
NCT03422445 A Study of Apatinib Combined With Temozolomide in Patients Witn Advanced Melanoma Status UNKNOWN Phase PHASE2
NCT03419403 UNITE Study: Understanding New Interventions With GBM ThErapy Status TERMINATED Phase PHASE3
NCT03388372 Nimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral Glioblastoma Status COMPLETED Phase PHASE2
NCT03387592 CAPTEM or FOLFIRI as SEcond-line Therapy in NEuroendocrine CArcinomas Status TERMINATED Phase PHASE2
NCT03363659 Disulfiram and Copper Gluconate With Temozolomide in Unmethylated Glioblastoma Multiforme Status TERMINATED Phase PHASE2
NCT03351296 Two Chemotherapy Regimens Plus or Minus Bevacizumab Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03345095 A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma Status COMPLETED Phase PHASE3
NCT03323034 Pevonedistat, Irinotecan, and Temozolomide in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphoma Status COMPLETED Phase PHASE1
NCT03310372 Concomitant Association of Ultrafractionated Brain Irradiation - Temozolomide in Inoperable Primary Glioblastoma Multiforme Status COMPLETED Phase PHASE2
NCT03291990 5 Fraction Stereotactic Radiosurgery With Temozolomide for Glioblastoma Multiforme Status COMPLETED Phase EARLY_PHASE1